Organon & Co Capital Reinvestment Ratio
Organon & Co capital reinvestment ratio. Organon & Co (OGN) has a Capital Reinvestment Ratio of 0.39x as of June 2026, meaning it reinvests 0% of its operating cash flow ($107.00 Million) in capital expenditures ($42.00 Million). See OGN free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Organon & Co (2017–2025)
Capital reinvestment ratio of Organon & Co from 2017 to 2025. This chart tracks Organon & Co's Capital Reinvestment Ratio across 9 annual periods. See financial agility of Organon & Co to measure the company's free cash flow as a share of total liabilities.
Organon & Co Capital Reinvestment Ratio by Year (2017–2025)
Organon & Co capital reinvestment ratio by year from 2017 to 2025. For the full cash flow conversion analysis, see cash flow conversion of Organon & Co.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | $700.00 Million | $162.00 Million | ▼ -38.1% |
| 2024 | 0.37x | $939.00 Million | $351.00 Million | ▲ +14.4% |
| 2023 | 0.33x | $799.00 Million | $261.00 Million | ▼ -34.4% |
| 2022 | 0.50x | $858.00 Million | $427.00 Million | ▲ +150.7% |
| 2021 | 0.20x | $2.46 Billion | $488.00 Million | ▲ +56.2% |
| 2020 | 0.13x | $2.19 Billion | $278.00 Million | ▲ +282.3% |
| 2019 | 0.03x | $2.77 Billion | $92.00 Million | ▲ +21.4% |
| 2018 | 0.03x | $3.69 Billion | $101.00 Million | ▲ +8.9% |
| 2017 | 0.03x | $3.42 Billion | $86.00 Million | — |